{{Rsnum
|rsid=337718
|Chromosome=18
|position=72107043
|Orientation=plus
|GMAF=0.3352
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 39.8 | 7.1
| HCB | 41.6 | 50.4 | 8.0
| JPT | 46.0 | 46.0 | 8.0
| YRI | 36.3 | 52.1 | 11.6
| ASW | 31.6 | 49.1 | 19.3
| CHB | 41.6 | 50.4 | 8.0
| CHD | 50.5 | 40.4 | 9.2
| GIH | 50.5 | 43.6 | 5.9
| LWK | 36.4 | 42.7 | 20.9
| MEX | 53.4 | 39.7 | 6.9
| MKK | 33.3 | 46.2 | 20.5
| TSI | 51.0 | 39.2 | 9.8
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000009
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs337718
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 18q22.3; Reported Gene(s): CBLN2; Risk Allele: rs337718-?); (p-value= 0.000009).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740732
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs337718
|overall_frequency_n=82
|overall_frequency_d=126
|overall_frequency=0.650794
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=68
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}